Drugs / Japanese Encephalitis Vaccine (Vero Cell), Inactivated
Japanese Encephalitis Vaccine (Vero Cell), Inactivated
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06825312 | Nov 2023 → Dec 2030 expected | Japanese encephalitis | Liaoning Chengda Biotechnology CO., LTD | Active not recruiting | No outcome recorded |
| Phase 4 | NCT04817917 | Mar 2021 → Sep 2022 | Japanese encephalitis | Zhejiang Provincial Center for Disease Control and Prevention | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Japanese Encephalitis Vaccine (Vero Cell), Inactivated; | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04817917 ↗ |
| Modality | Vaccine | “by JE attenuated live vaccine (JEV-L) or/and inactivated vaccine (JEV-I)” NCT04817917 ↗ |
| Route | Intramuscular | “administered in the deltoid area of lateral arm by intramuscular injection” NCT06825312 ↗ |